Structural Phylogenomics: Selection Pressure Suggests the Functionally Important Residues Encoded by Cisplatin Resistance Related 9 Gene

Authors

  • Saadia Shakir Institute of Pharmaceutical and Environmental Research (IPER), Dow University of Health Sciences, Karachi, Pakistan
  • Waqas Ahmed Waseem Institute of Pharmaceutical and Environmental Research (IPER), Dow University of Health Sciences, Karachi, Pakistan.
  • Syed Khaqan Hasan Institute of Pharmaceutical and Environmental Research (IPER),1 Department of Molecular Pathology,2 Dow University of Health Sciences, Karachi, Pakistan.
  • Muhammad Munir Department of Molecular Pathology, Dow University of Health Sciences, Karachi, Pakistan.
  • Muhammad Rafiq Khanani Department of Molecular Pathology, Dow University of Health Sciences, Karachi, Pakistan.
  • Mushtaq Hussain Department of Molecular Pathology, Dow University of Health Sciences, Karachi, Pakistan

Keywords:

CRR9, cisplatin, structural phylogenomics, molecular evolution

Abstract

Cisplatin Resistance Related 9 gene, CRR9, contributes towards the efficacy of the chemotherapeutic drug namely cisplatin. Genetic studies have established the association between CRR9 gene mutations and several cancers, but the structure-function aspects of the encoded protein remains largely unaddressed. In the present study, we have constructed a consensus phylogenetic tree of the CRR9 gene using maximum likelihood method after 1000 bootstrap replicates. Multiple sequence alignment of the selected orthologs was undertaken and important variations were analyzed with reference to the clade segregations and spatial locations in the constructed protein structure models. The topology of the phylogenetic tree appears in line with the established phylogenetic relationship of the mammalian lineage. The protein models of selected mammalian representatives suggest strong uniformity as Root Mean Square Deviation which varies from 0.03Å to 0.14Å. Both the DAS
server and protein structure suggest the presence of two novel transmembrane regions ranging from Val461 to Ala483 and Thr490 to Tyr506. Multiple sequence alignment of the protein showed primate specific amino acid substitutions. Importantly, these variations are mostly situated in the core part of the protein structure implying their structural and/or functional significance. 

Downloads

Download data is not yet available.

References

Jamieson ER, Lippard SJ. Structure, Recognition, and Processing of Cisplatin-DNA Adducts. Chem Rev 1999;

:2467-98.

Alderden RA, Mellor HR, Modok S, Hambley TW, Callaghan R. Cytotoxic efficacy of an anthraquinone

linked platinum anticancer drug. Biochem Pharmacol 2006; 71:1136-45.

Ohndorf UM, Whitehead JP, Raju NL, Lippard SJ. Binding of tsHMG, a mouse testis-specific HMG-domain

protein, to cisplatin-DNA adducts. Biochemistry 1997; 36:14807-15.

Zhu G, Lippard SJ. Photoaffinity labeling reveals nuclear proteins that uniquely recognize cisplatin-DNA

interstrand cross-links. Biochemistry 2009; 48:4916-25.

Zhu W, Li Y, Liu L, Chen Y, Wang C, Xi F. Supramolecular Hydrogels from Cisplatin-Loaded Block Copolymer Nanoparticles and alpha-Cyclodextrins with a Stepwise Delivery Property. Biomacromolecules 2010.

Taniguchi K, Wada M, Kohno K, Nakamura T, Kawabe T, Kawakami M, et al. A human canalicular multispecific

organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res 1996; 56:4124-9.

Vaisman A, Varchenko M, Umar A, Kunkel TA, Risinger JI, Barrett JC, et al. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts. Cancer Res 1998; 58:3579-85.

Yamamoto K, Okamoto A, Isonishi S, Ochiai K, Ohtake Y. A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem Biophys Res Commun 2001; 280:1148-54.

Zienolddiny S, Skaug V, Landvik NE, Ryberg D, Phillips DH, Houlston R, et al. The TERT-CLPTM1L lung

cancer susceptibility variant associates with higher DNA adduct formation in the lung. Carcinogenesis 2009; 30:1368-71.

Hu Z, Wu C, Shi Y, Guo H, Zhao X, Yin Z, et al. A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet 2011; 43:792-6.

Pande M, Spitz MR, Wu X, Gorlov IP, Chen WV, Amos CI. Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. Carcinogenesis2011; 32:1493-9.

Turnbull C, Rahman N. Genome-wide association studies provide new insights into the genetic basis of testicular germ-cell tumour. Int J Androl 2011; 34:e86-96.

Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 25:4876-82.

Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 1980; 16:111-20.

Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011; 28:2731-9.

Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 1985; 39:783-91.

Rose PW, Beran B, Bi C, Bluhm WF, Dimitropoulos D, Goodsell DS, et al. The RCSB Protein Data Bank: redesigned web site and web services. Nucleic Acids Res 2011; 39:D392-401.

Roy A, Kucukural A, Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 2010; 5:725-38.

Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen MY, et al. Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics 2006; Chapter 5:Unit 5 6.

Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997; 18:2714-23.

Chen VB, Arendall WB 3rd, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 2010; 66:12-21.

Venditti C, Meade A, Pagel M. Multiple routes to mammalian diversity. Nature 2011.

Heath TA, Zwickl DJ, Kim J, Hillis DM. Taxon sampling affects inferences of macroevolutionary processes from

phylogenetic trees. Syst Biol 2008; 57:160-6.

Bininda-Emonds OR, Cardillo M, Jones KE, MacPhee RD, Beck RM, Grenyer R, et al. The delayed rise of present-day mammals. Nature 2007; 446:507-12.

Archibald JD, Deutschmann DH. Quantitative analysis of the timing of the origin and diversification of extant placental orders. J Mamm Evol 2001; 8:107-24.

Asher RJ, Meng J, Wible JR, McKenna MC, Rougier GW, Dashzeveg D, et al. Stem Lagomorpha and the antiquity of Glires. Science 2005; 307:1091-4.

Bromham L, Phillips MJ, Penny D. Growing up with dinosaurs: molecular dates and the mammalian radiation.

Trends Ecol Evol 1999; 14:113-8.

Downloads

Published

2015-12-28

How to Cite

Shakir, S., Waseem, W. A. ., Hasan, S. K., Munir, M., Khanani, M. R., & Hussain, M. (2015). Structural Phylogenomics: Selection Pressure Suggests the Functionally Important Residues Encoded by Cisplatin Resistance Related 9 Gene. Journal of the Dow University of Health Sciences (JDUHS), 5(3), 111–117. Retrieved from https://www.jduhs.com/index.php/jduhs/article/view/1489

Issue

Section

Original Articles

Most read articles by the same author(s)